NIOX Group Plc (LON:NIOX - Get Free Report)'s stock price traded up 0.3% during trading on Wednesday . The company traded as high as GBX 64.40 ($0.87) and last traded at GBX 64 ($0.86). 1,419,964 shares changed hands during mid-day trading, an increase of 5% from the average session volume of 1,351,022 shares. The stock had previously closed at GBX 63.80 ($0.86).
Wall Street Analysts Forecast Growth
NIOX has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 90 ($1.21) price target on shares of NIOX Group in a research note on Tuesday, April 15th. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 90 ($1.21) price objective on shares of NIOX Group in a research report on Tuesday, April 15th.
View Our Latest Report on NIOX
NIOX Group Stock Performance
The stock has a market capitalization of £27.35 billion, a PE ratio of 2,748.47 and a beta of 0.92. The business's fifty day moving average price is GBX 66.18 and its 200-day moving average price is GBX 63.75. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.31 and a quick ratio of 1.94.
NIOX Group (LON:NIOX - Get Free Report) last released its quarterly earnings results on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) EPS for the quarter. NIOX Group had a net margin of 28.21% and a return on equity of 13.29%. As a group, equities research analysts expect that NIOX Group Plc will post 1.1658256 EPS for the current year.
Insider Activity at NIOX Group
In related news, insider Ian Johnson sold 3,924,630 shares of the company's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of GBX 65 ($0.87), for a total transaction of £2,551,009.50 ($3,432,467.03). Also, insider Jonathan Emms sold 2,745,925 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of GBX 65 ($0.87), for a total transaction of £1,784,851.25 ($2,401,575.96). 46.72% of the stock is currently owned by insiders.
About NIOX Group
(
Get Free Report)
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
Further Reading
Before you consider NIOX Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NIOX Group wasn't on the list.
While NIOX Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
